A Study to Evaluate if AC-084 is Safe, Its Fate in the Body as Well as Its Potential Effects on the Body in Healthy Subjects

PHASE1TerminatedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 12, 2016

Primary Completion Date

December 10, 2017

Study Completion Date

December 10, 2017

Conditions

Healthy Subjects

Interventions

DRUG

AC-084

Hard gelatin capsules for oral administration formulated in strengths of 1 mg, 10 mg, and 100 mg

DRUG

Placebo

Placebo capsules matching AC-084 capsules

Trial Locations (1)

Covance Clinical Research Unit, Leeds